ARTHROPLASTY
Gabapentin improves in-hospital rehabilitation but not post-discharge outcomes after TKA
This report has been verified
by one or more authors of the
original publication.
Br J Anaesth. 2014 Nov;113(5):855-64.
179 patients undergoing total knee arthroplasty (TKA) were randomized to receive a four day perioperative regimen of either gabapentin or placebo as an adjunct to celecoxib. The primary intent of this trial was to determine whether gabapentin improves in-hospital rehabilitation and physical function 4 days, 6 weeks, and 3 months after surgery. No significant differences in favour of gabapentin were observed with respect to pain and physical function at any follow-up time point. However, gabapentin decreased morphine consumption in the first 24 hours after surgery, reduced the incidence of nausea, pruritus and dizziness, and increased in-hospital knee range of motion compared to placebo.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
